Jane Street
KYNB

Jane Street’s Kyntra Bio KYNB Stock Holding History

Jane Street’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,064
Closed -$62.5K – 9601
2024
Q1 		$62.5K Buy
1,064
+248
+30% +$10.7K ﹤0.01% 8689
2023
Q4 		$18.1K Sell
816
-388
-32% -$5.85K ﹤0.01% 8922
2023
Q3 		$26K Sell
1,204
-28,112
-96% -$1.1M ﹤0.01% 8270
2023
Q2 		$1.98M Buy
29,316
+28,860
+6,329% +$11.9M ﹤0.01% 4175
2023
Q1 		$213K Sell
456
-2,380
-84% -$1.26M ﹤0.01% 7753
2022
Q4 		$1.14M Buy
2,836
+1,496
+112% +$573K ﹤0.01% 4779
2022
Q3 		$436K Buy
1,340
+236
+21% +$76K ﹤0.01% 6927
2022
Q2 		$291K Sell
1,104
-1,148
-51% -$293K ﹤0.01% 7658
2022
Q1 		$677K Buy
2,252
+420
+23% +$146K ﹤0.01% 6916
2021
Q4 		$646K Buy
1,832
+568
+45% +$177K ﹤0.01% 6784
2021
Q3 		$323K Sell
1,264
-14,680
-92% -$5.2M ﹤0.01% 8040
2021
Q2 		$10.6M Buy
15,944
+15,620
+4,821% +$9M ﹤0.01% 1640
2021
Q1 		$281K Sell
324
-8,152
-96% -$8.68M ﹤0.01% 7797
2020
Q4 		$7.86M Buy
8,476
+7,604
+872% +$7.99M ﹤0.01% 1629
2020
Q3 		$896K Sell
872
-716
-45% -$770K ﹤0.01% 4276
2020
Q2 		$1.61M Buy
+1,588
New +$1.47M ﹤0.01% 3366

Other funds holding KYNB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Jane Street's KYNB Position: Q1 2026 in Review

Jane Street reduced its Kyntra Bio (KYNB) stake by 2.2% in Q1 2026, selling an estimated $2.1K and leaving 12,228 shares worth $82.9K. The position accounts for ﹤0.01% of the portfolio, ranked #10729.

Jane Street first reported a position in KYNB in Q2 2015 and has held it in 32 quarters since. The position peaked at $8.47M in Q1 2023. 32 funds tracked by Wall St. Rank hold KYNB as of Q1 2026.

  • Jane Street held 12,228 shares of Kyntra Bio worth $82.9K as of Q1 2026.
  • Jane Street sold 269 Kyntra Bio shares in Q1 2026, an estimated $2.1K.
  • Kyntra Bio made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10729 holding.
  • Jane Street first reported a position in Kyntra Bio in Q2 2015 and has held it in 32 quarters since.
  • Jane Street's Kyntra Bio position peaked at $8.47M in Q1 2023.
  • 32 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.